Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ketamine in Suicidal Adolescents
NCT02048423Phase 3Unknown
- Sponsor
- Nationwide Children's Hospital
- Start
- Jun 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in major depressive disorder (MDD), bipolar disorder (BD), suicidal ideation, sponsored by Nationwide Children's Hospital. Status: unknown.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)suicidal ideation
Beyond the preview
Go deeper on NCT02048423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048423.